计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| F129882-5mg |
5mg |
现货 ![]() |
| |
| F129882-25mg |
25mg |
现货 ![]() |
| |
| F129882-100mg |
100mg |
现货 ![]() |
| |
| F129882-500mg |
500mg |
现货 ![]() |
|
| 别名 | 铁抑制剂-1 | 3-氨基-4-(环己基氨基)苯甲酸乙酯 | 3-氨基-4-环己基氨基苯甲酸乙酯 |
|---|---|
| 英文别名 | Ethyl 3-amino-4-(cyclohexylamino)benzoate | 3-Amino-4-cyclohexylaminobenzoic Acid Ethyl Ester |
| 规格或纯度 | Moligand™, ≥99% |
| 英文名称 | Ferrostatin-1 (Fer-1) |
| 生化机理 | 铁抑制剂-1是一种活性自由基捕获抗氧化剂,能够捕获过氧自由基,可用作铁死亡的潜在抑制剂。铁死亡被认为是调节性坏死,和细胞凋亡和自吞噬不同。铁抑制剂-1能够保护人们免于亨廷顿病,还能在细胞模型中防止谷氨酸诱导的神经毒性。 铁抑制剂-1是一种高效的非凋亡的,erastin诱导铁死亡细胞死亡抑制剂。铁抑制剂-1能够防止癌症细胞中铁死亡细胞死亡和器官型大鼠脑切片中谷氨酸诱导毒性。铁抑制剂-1控制脂溶解ROS。 |
| 储存温度 | 2-8°C储存,避光,充氩 |
| 运输条件 | 冰袋运输 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
Ferrostatin-1 (Fer-1) 是一种有效的、选择性的 ferroptosis 抑制剂,抑制 Erastin 诱导的 HT-1080 细胞铁死亡 (EC50=60 nM)。Ferrostatin-1 是一种人工合成的抗氧化剂,通过还原机制来防止膜脂的损伤,从而抑制细胞死亡。Ferrostatin-1 具有抗真菌活性。
Ferrostatin-1 (Fer-1) is a potent and selective inhibitor of ferroptosis with EC50 of 60 nM.
Ferrostatin-1 (Fer-1), a potent and selective ferroptosis inhibitor, suppresses Erastin-induced ferroptosis in HT-1080 cells (EC50=60 nM). Ferrostatin-1, a synthetic antioxidant, acts via a reductive mechanism to prevent damage to membrane lipids and thereby inhibits cell death. Ferrostatin-1 exhibits antifungal activity.
|
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504762826 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | ethyl 3-amino-4-(cyclohexylamino)benzoate |
| INCHI | 1S/C15H22N2O2/c1-2-19-15(18)11-8-9-14(13(16)10-11)17-12-6-4-3-5-7-12/h8-10,12,17H,2-7,16H2,1H3 |
| InChi Key | UJHBVMHOBZBWMX-UHFFFAOYSA-N |
| Smiles | CCOC(=O)C1=CC(=C(C=C1)NC2CCCCC2)N |
| Isomeric SMILES | CCOC(=O)C1=CC(=C(C=C1)NC2CCCCC2)N |
| 分子量 | 262.35 |
| Reaxy-Rn | 9413226 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9413226&ln= |
| 溶解性 | DMSO 52 mg/mL Water <1 mg/mL Ethanol 52 mg/mL |
|---|---|
| 敏感性 | 对光线、空气、热敏感 |
| 熔点 | 106 °C |
| 分子量 | 262.350 g/mol |
| XLogP3 | 3.300 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 4 |
| 可旋转键计数Rotatable Bond Count | 5 |
| 精确质量Exact Mass | 262.168 Da |
| 单同位素质量Monoisotopic Mass | 262.168 Da |
| 拓扑极表面积Topological Polar Surface Area | 64.400 Ų |
| 重原子数Heavy Atom Count | 19 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 290.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P264: 处理后要彻底洗手。 P271: 仅在室外或通风良好的地方使用。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P302+P352: 如皮肤沾染:用水充分清洗。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P405: 密闭存放 P403+P233: 存放在通风良好的地方。保持容器密闭。 P501: 将内容物/容器处理到。。。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 | |
| 分析证书 | F129882 |
¥299.90
| 1. Henning Y et al.. (2022) Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction.. Cell Death Dis, 13 (7): (662). [PMID:35906211] |
| 2. Wenzel SE et al.. (2017) PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals.. Cell, 171 (3): (628-641.e26). [PMID:29053969] |
| 3. Xiaosi Lin , Le Dong, Qing Miao, Zhaobin Huang, Fang Wang. (2024) Cycloheptylprodigiosin from marine bacterium Spartinivicinus ruber MCCC 1K03745T induces a novel form of cell death characterized by Golgi disruption and enhanced secretion of cathepsin D in non-small cell lung cancer cell lines. European Journal of Pharmacology, 无 (974): (176608). [PMID:38663542] [10.1016/j.ejphar.2024.176608] |
| 4. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). [PMID:38194774] [10.1016/j.ejmech.2023.116110] |
| 5. Tianxiang Wang, Changmei Yang, Zhiqiang Li, Ting Li, Ran Zhang, Yujiao Zhao, Tianyi Cheng, Zhaoyun Zong, Yingying Ma, Dongyuan Zhang, Haiteng Deng. (2024) Flavonoid 4,4′-dimethoxychalcone selectively eliminates senescent cells via activating ferritinophagy. Redox Biology, 69 (103017). [PMID:38176315] [10.1016/j.redox.2023.103017] |
| 6. Yijing Yang, Ying Wang, Ying Deng, Jing Lu, Li Xiao, Jie Li, Yasha Zhou, Fujiao Nie, Xiangdong Chen, Jun Peng, Hanyu Tan, Yuhui Qin, Qinghua Peng. (2023) Fructus Lycii and Salvia miltiorrhiza Bunge extract attenuate oxidative stress-induced photoreceptor ferroptosis in retinitis pigmentosa. BIOMEDICINE & PHARMACOTHERAPY, 167 (115547). [PMID:37741257] [10.1016/j.biopha.2023.115547] |
| 7. Xi Wang, Wenjing Zhu, Miao Xing, Haiyan Zhu, Enqing Chen, Jie Zhou. (2023) Matrine disrupts Nrf2/GPX4 antioxidant system and promotes hepatocyte ferroptosis. CHEMICO-BIOLOGICAL INTERACTIONS, 384 (110713). [PMID:37716422] [10.1016/j.cbi.2023.110713] |
| 8. Suleixin Yang, Yi Wu, Wenzhao Zhong, Ruie Chen, Meilin Wang, Meiwan Chen. (2023) GSH/Ph Dual Activatable Crosslinked And Fluorinated Pei for Cancer Gene Therapy Through Endogenous Iron De-Hijacking And in Situ Ros Amplification. ADVANCED MATERIALS, (2304098). [PMID:37689975] [10.1002/adma.202304098] |
| 9. Wei Li, Chang Liu, Sichuan Wang, Naifeng Liu. (2023) Neutrophil membrane biomimetic delivery system (Ptdser-NM-Lipo/Fer-1) designed for targeting atherosclerosis therapy. IET Nanobiotechnology, 17 (4): (387-395). [PMID:37183611] [10.1049/nbt2.12137] |
| 10. Zhao Hongting, Zhang Meng, Zhang Jinghua, Sun Zichen, Zhang Wenxin, Dong Weichen, Cheng Chen, Yao Yongzhong, Li Kuanyu. (2023) Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth. Cell and Bioscience, 13 (1): (1-15). [PMID:37179385] [10.1186/s13578-023-01044-0] |
| 11. Yu-Chen Chen, Qiong Zheng, Hui Lu, Yi-Xin Zhuang, Ting-Ting Gong, Lie-Feng Ma, Zha-Jun Zhan. (2023) Neuroprotective flavonoids from Epimedium brevicornu by inhibition of ferroptosis. Phytochemistry Letters, 55 (80). [10.1016/j.phytol.2023.04.003] |
| 12. Xia Chen, Rong Wu, Lei Li, Yunong Zeng, Jingrui Chen, Mingyuan Wei, Yinglin Feng, Guiming Chen, Yuhang Wang, Lizhen Lin, Haihua Luo, Ali Chen, Zhenhua Zeng, Fangjie He, Yang Bai, Siyou Zhang, Yubing Han, Zhang Wang, Xiaoshan Zhao, Wei Xiao, Yong Jiang, Shenhai Gong. (2023) Pregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation. IMMUNITY, 56 (336-352.e9). [PMID:36792573] [10.1016/j.immuni.2023.01.015] |
| 13. Wenhua Wang, Wenhao Wang, Shiwei Jin, Fangqin Fu, Zhengwei Huang, Ying Huang, Chuanbin Wu, Xin Pan. (2023) Open pocket and tighten holes: Inhalable lung cancer-targeted nanocomposite for enhanced ferroptosis-apoptosis synergetic therapy. CHEMICAL ENGINEERING JOURNAL, 458 (141487). [10.1016/j.cej.2023.141487] |
| 14. Huiyi Li, Qiqing Weng, Shuai Gong, Weixian Zhang, Jiaqi Wang, Yuqiao Huang, Yuanjun Li, Jiao Guo, Tian Lan. (2023) Kaempferol prevents acetaminophen-induced liver injury by suppressing hepatocyte ferroptosis via Nrf2 pathway activation. Food & Function, 14 (4): (1884-1896). [PMID:36723004] [10.1039/D2FO02716J] |
| 15. Mingbo Wu, Wenwu Ling, Jiaojun Wei, Ran Liao, Haiyue Sun, Dongqiu Li, Ye Zhao, Long Zhao. (2022) Biomimetic photosensitizer nanocrystals trigger enhanced ferroptosis for improving cancer treatment. JOURNAL OF CONTROLLED RELEASE, 352 (1116). [PMID:36402233] [10.1016/j.jconrel.2022.11.026] |
| 16. Huan Huang, Yuling Chen, Na Yin, Gaojie Li, Shanshan Ye, Ling Guo, Min Feng. (2023) Unsaturated Fatty Acid Liposomes Selectively Regulate Glutathione Peroxidase 4 to Exacerbate Lipid Peroxidation as an Adaptable Liposome Platform for Anti-Tumor Therapy. MOLECULAR PHARMACEUTICS, 20 (1): (290–302). [PMID:36368878] [10.1021/acs.molpharmaceut.2c00642] |
| 17. Li Xie, Wenjie Chen, Qifang Chen, Yang Jiang, Erqun Song, Xiaokang Zhu, Yang Song. (2022) Synergistic hydroxyl radical formation, system XC- inhibition and heat shock protein crosslinking tango in ferrotherapy: A prove-of-concept study of “sword and shield” theory. Materials Today Bio, 16 (100353). [PMID:35865409] [10.1016/j.mtbio.2022.100353] |
| 18. Shuwei Qiao, Baosheng Li, Qing Cai, Zhen Li, Zhaoyi Yin, Jie He, Yuyang Li, Weiyan Meng. (2022) Involvement of ferroptosis in Porphyromonas gingivalis lipopolysaccharide-stimulated periodontitis in vitro and in vivo. ORAL DISEASES, [PMID:35765229] [10.1111/odi.14292] |
| 19. Hao Chi, Guang Zhu, Yalin Yin, He Diao, Zicheng Liu, Shibo Sun, Zhaoming Guo, Weiping Xu, Jianqiang Xu, Changhao Cui, Xiao-Jin Xing, Kun Ma. (2022) Dual-Responsive multifunctional “core–shell” magnetic nanoparticles promoting Fenton reaction for tumor ferroptosis therapy. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 622 (121898). [PMID:35688287] [10.1016/j.ijpharm.2022.121898] |
| 20. Feng-guo Zhai, Qi-chao Liang, Yi-yan Wu, Jia-qi Liu, Jia-wei Liu. (2022) Red ginseng polysaccharide exhibits anticancer activity through GPX4 downregulation-induced ferroptosis. PHARMACEUTICAL BIOLOGY, 60 (1): (909-914). [PMID:35575436] [10.1080/13880209.2022.2066139] |
| 21. Wenhao Wang, Fangqin Fu, Zhengwei Huang, Wenhua Wang, Minglong Chen, Xiao Yue, Jintao Fu, Xiaoqian Feng, Ying Huang, Chuanbin Wu, Xin Pan. (2022) Inhalable Biomimetic Protein Corona-Mediated Nanoreactor for Self-Amplified Lung Adenocarcinoma Ferroptosis Therapy. ACS Nano, 16 (5): (8370–8387). [PMID:35575209] [10.1021/acsnano.2c02634] |
| 22. Fengfan Liu, Xiang Cheng, Shuang Wu, Bei Hu, Chen Yang, Shufen Deng, Qiwen Shi. (2022) Nickel oxide nanoparticles induce apoptosis and ferroptosis in airway epithelial cells via ATF3. ENVIRONMENTAL TOXICOLOGY, 37 (5): (1093-1103). [PMID:35061333] [10.1002/tox.23467] |
| 23. Haibao Peng, Xingcai Zhang, Peng Yang, Jiaxu Zhao, Wei Zhang, Nianping Feng, Wuli Yang, Jing Tang. (2023) Defect self-assembly of metal-organic framework triggers ferroptosis to overcome resistance. Bioactive Materials, 19 (1). [PMID:35415315] [10.1016/j.bioactmat.2021.12.018] |
| 24. Zhiwei Wang, Mingxing Li, Yuanfeng Liu, Zhentao Qiao, Tao Bai, Ling Yang, Bo Liu. (2021) Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression. ONCOLOGY REPORTS, 46 (5): (1-14). [PMID:34558645] [10.3892/or.2021.8191] |
| 25. Rong Fan, Jidong Sui, Xuepeng Dong, Biao Jing, Zhenming Gao. (2021) Wedelolactone alleviates acute pancreatitis and associated lung injury via GPX4 mediated suppression of pyroptosis and ferroptosis. FREE RADICAL BIOLOGY AND MEDICINE, 173 (29). [PMID:34246777] [10.1016/j.freeradbiomed.2021.07.009] |
| 26. Xiazhen Bao, Xuehui Cao, Yong Yuan, Bo Zhou, Congde Huo. (2021) A water-soluble, highly sensitive and ultrafast fluorescence probe for imaging of mitochondrial hypochlorous acid. SENSORS AND ACTUATORS B-CHEMICAL, 344 (130210). [10.1016/j.snb.2021.130210] |
| 27. Wenjun Liu, Jieyuan Zhang, Liang Ding, Weifeng Ni, Junjie Yuan, Haijun Xiao, Jingwei Zhang. (2021) RBC-derived nanosystem with enhanced ferroptosis triggered by oxygen-boosted phototherapy for synergized tumor treatment. Biomaterials Science, 9 (21): (7228-7236). [PMID:34585181] [10.1039/D1BM00175B] |
| 28. Tao Bai, Ruopeng Liang, Rongtao Zhu, Weijie Wang, Lin Zhou, Yuling Sun. (2020) MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells. JOURNAL OF CELLULAR PHYSIOLOGY, 235 (7-8): (5637-5648). [PMID:31960438] [10.1002/jcp.29496] |
| 29. Guo Lin, Zhang Jia, Li Yuqiang, Gao Yuehong, Huang Jiali, Liu Mengru, Li Jing, Chai Wenshu, Li Yubin. (2025) 3,3′-diindolylmethane induces ferroptosis and inhibits proliferation in non-small-cell lung cancer through the AHR/NRF2/GPX4 axis. Discover Oncology, 16 (1): (1-18). [PMID:40100489] [10.1007/s12672-025-02096-z] |
| 30. Shanshan Guo, Lang Zhou, Xueqi Liu, Li Gao, Yuanyuan Li, Yonggui Wu. (2024) Baicalein alleviates cisplatin-induced acute kidney injury by inhibiting ALOX12-dependent ferroptosis. PHYTOMEDICINE, 130 (155757). [PMID:38805781] [10.1016/j.phymed.2024.155757] |
| 31. Xiaosi Lin, Le Dong, Qing Miao, Zhaobin Huang, Fang Wang. (2024) Cycloheptylprodigiosin from marine bacterium Spartinivicinus ruber MCCC 1K03745T induces a novel form of cell death characterized by Golgi disruption and enhanced secretion of cathepsin D in Non-small cell lung cancer cell lines. EUROPEAN JOURNAL OF PHARMACOLOGY, (176608). [PMID:38663542] [10.1016/j.ejphar.2024.176608] |
| 32. Zi-Han Xu, Ming-Min Xie, Chun-Lan Xie, Xian-Wen Yang, Jun-Song Wang. (2025) Deep-Sea-Derived Isobisvertinol Targets TLR4 to Exhibit Neuroprotective Activity via Anti-Inflammatory and Ferroptosis-Inhibitory Effects. Marine Drugs, 23 (1): (49). [PMID:39852551] [10.3390/md23010049] |
| 33. Xinyu Zhang, Hui Liu, Chenyu Wang, Yuan Gao, Shiqi Zhao, Mengyao Mu, Ke Ren, Yufang Gong, Qing Fan, Xiao Sun. (2025) Dimeric PD-L1 specific affibody grafted Fe-based nanosheets for tumor-targeting dual-mode magnet resonance imaging and enhancement of Photothermal-Immunotherapy. CHEMICAL ENGINEERING JOURNAL, (159400). [10.1016/j.cej.2025.159400] |
| 34. Xiaoyu Wang, Chunzhe Xu, Hantao Tian, Yu Pang, Jie Lv, Meng Li. (2025) FeS embedded bioreactor collaborate with artesunate for cascade-catalytic tumor ferroptosis. JOURNAL OF COLLOID AND INTERFACE SCIENCE, (137479). [PMID:40184656] [10.1016/j.jcis.2025.137479] |
| 35. Lei Shu, Peili Luo, Qingxin Chen, Jingyang Liu, Ying Huang, Chuanbin Wu, Xin Pan, Zhengwei Huang. (2024) Fibroin nanodisruptor with Ferroptosis-Autophagy synergism is potent for lung cancer treatment. INTERNATIONAL JOURNAL OF PHARMACEUTICS, (124582). [PMID:39142466] [10.1016/j.ijpharm.2024.124582] |
| 36. Jiani Zhan, Yijia Chen, Yuying Liu, Yunqiu Chen, Zhiyao Li, Xuewen Li, Zhenning He, Fangzhou Meng, Xiaoyang Qian, Lili Yang, Qing Yang. (2025) IDO1-mediated AhR activation up-regulates pentose phosphate pathway via NRF2 to inhibit ferroptosis in lung cancer. BIOCHEMICAL PHARMACOLOGY, (116913). [PMID:40164341] [10.1016/j.bcp.2025.116913] |
| 37. Chen Kechun, Xu Bingtian, Long Lu, Wen Huizhen, Zhao Qian, Tu Xingxing, Wang Jiakang, Xu Jiangping, Wang Haitao. (2024) Inhibition of Phosphodiesterase 4 Suppresses Neuronal Ferroptosis After Cerebral Ischemia/Reperfusion. MOLECULAR NEUROBIOLOGY, (1-20). [PMID:39287745] [10.1007/s12035-024-04495-9] |
| 38. Yu Fu, Guiqin Huang, Yawen Cai, Menghui Ren, Run Cheng, Yuhui Chai, Yingdi Wang, Yunqi An, Tianhua Yan, Lingpeng Zhu, Xinxin Liu. (2025) Integrated network pharmacology, bioinformatics, and experiment analysis to decipher the molecular mechanism of Salidroside on Gastric cancer via targeting NCOA4-mediated ferritinophagy. CHEMICO-BIOLOGICAL INTERACTIONS, (111368). [PMID:39746501] [10.1016/j.cbi.2024.111368] |
| 39. Xue Panpan, Zhuang Huilan, Bai Tingjie, Zeng Xuemei, Deng Jinpeng, Shao Sijie, Yan Shuangqian. (2024) Iron (II)-based metal-organic framework nanozyme for boosting tumor ferroptosis through inhibiting DNA damage repair and system Xc-. JOURNAL OF NANOBIOTECHNOLOGY, 22 (1): (1-16). [PMID:38715049] [10.1186/s12951-024-02508-2] |
| 40. Wenying Wei, Haifei Kang, Chenxi Lian, Jiawei Liu, Jinwei Lin, Junwei Yang, Zhangmancang Xu, Ziqi Wang, Meizhen Yin, Honglian Dai. (2024) Iron-based magnetic nanocomplexes for combined chemodynamic and photothermal cancer therapy through enhanced ferroptosis. Biomaterials Advances, (214046). [PMID:39332345] [10.1016/j.bioadv.2024.214046] |
| 41. Haiyan Zhu, Yijing Yang, Yenan Duan, Xin Zheng, Zixiong Lin, Jie Zhou. (2024) Nrf2/FSP1/CoQ10 axis-mediated ferroptosis is involved in sodium aescinate-induced nephrotoxicity. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 759 (110100). [PMID:39033970] [10.1016/j.abb.2024.110100] |
| 42. Shuheng Qin, Hui-yue Zhao, Xing-yu Luo, Fei Wang, Jun Liu, Yin Ding, Yong Hu. (2024) Photothermally Reinforced Nanozyme Remodeling Tumor Microenvironment of Redox and Metabolic Homeostasis to Enhance Ferroptosis in Tumor Therapy. ACS Nano, 18 (46): (32235-32254). [PMID:39499796] [10.1021/acsnano.4c13087] |
| 43. Lipeng Zhu, Dongliang Leng, Ziang Guo, Yuetao Zhao, Kam-Tong Leung, Yeneng Dai, Junnan Li, Qi Zhao. (2025) Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy. JOURNAL OF CONTROLLED RELEASE, 377 (524). [PMID:39580079] [10.1016/j.jconrel.2024.11.048] |
| 44. Fang Liu, Yaru Li, Yao Li, Zheng Wang, Xin Li, Yancheng Liu, Yanjun Zhao. (2025) Triggering multiple modalities of cell death via dual-responsive nanomedicines to address the narrow therapeutic window of β-lapachone. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 678 (915). [PMID:39270391] [10.1016/j.jcis.2024.09.063] |
| 45. Tianfeng Yang, Suyu Zhang, Kun Nie, Xiuhong Peng, Jian Huo, Xiao Fu, Yanmin Zhang. (2025) WWOX-mediated p53/SAT1 and NRF2/FPN1 axis contribute to toosendanin-induced ferroptosis in hepatocellular carcinoma. BIOCHEMICAL PHARMACOLOGY, (116790). [PMID:39894307] [10.1016/j.bcp.2025.116790] |